Annabell Linck

Title: Annabell Linck: Innovator in Non-Ribosomal Peptide Synthesis

Introduction

Annabell Linck is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of biochemistry, particularly in the assembly and modification of non-ribosomal peptide synthases (NRPS). Her innovative work has the potential to revolutionize peptide synthesis and expand the possibilities in pharmaceutical applications.

Latest Patents

Annabell Linck holds a patent for a "System for the assembly and modification of non-ribosomal peptide synthases." This invention pertains to a system that utilizes novel well-defined building blocks, known as eXchange Units (XU2.0), which allow for the efficient combination of assembly units regardless of their natural occurring specificity. The system enables the easy assembly of NRPS with any desired amino acid sequence, overcoming limitations imposed by naturally occurring NRPS units. Additionally, it facilitates the exchange of natural NRPS building blocks with the inventive XU2.0, leading to the production of modified peptides. The patent encompasses the system, individual exchange units, nucleic acids encoding these units, as well as methods and uses thereof.

Career Highlights

Annabell Linck is affiliated with Johann Wolfgang Goethe-Universität Frankfurt am Main, where she conducts her research and development. Her work has garnered attention for its innovative approach to peptide synthesis, contributing to advancements in the field.

Collaborations

Some of her notable coworkers include Helge B Bode and Kenan Bozhüyük, who have collaborated with her on various projects related to peptide synthesis and biochemistry.

Conclusion

Annabell Linck's contributions to the field of non-ribosomal peptide synthesis highlight her innovative spirit and dedication to advancing biochemistry. Her patent and ongoing research promise to open new avenues in peptide production and application.